DAFNA CAPITAL MANAGEMENT LLC CymaBay Therapeutics, Inc. Transaction History

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

$5.96M
portfolio value

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

+18.64%
quarter

CymaBay Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -4.72% -84.33K shares 688K $3.5 1.70M
Q2 2022 share Increase +5.61% 95K shares 9K $2.95 1.78M
Q1 2022 share Decrease -5.31% -95K shares -778K $3.11 1.69M
Q4 2021 share Increase +240.95% 1.26M shares 4.12M $3.3 1.78M
Q3 2021 share Increase +2.72% 13.9K shares -311K $3.65 524.28K
Q2 2021 share Increase +51.10% 172.61K shares 692K $4.36 510.38K
Q1 2021 share Increase 0.00% 337.77K shares 1.53M $4.54 337.77K
Q3 2020 share Decrease -100.00% -165.6K shares -578K $7.24 0
Q2 2020 share Increase 0.00% 165.6K shares 578K $3.49 165.6K
Q4 2019 share Decrease -100.00% -349.99K shares -1.79M $1.96 0
Q3 2019 share 0.00% 0 shares -714K $5.12 349.99K
Q2 2019 share Increase +25.53% 71.18K shares -1.19M $7.16 349.99K
Q1 2019 share Decrease -16.15% -53.7K shares 1.08M $13.28 278.81K
Q4 2018 share Increase +12.90% 38K shares -646K $7.87 332.51K
Q3 2018 share 0.00% 0 shares -689K $11.08 294.51K
Q2 2018 share Decrease -9.06% -29.33K shares -255K $13.42 294.51K
Q1 2018 share Decrease -10.33% -37.32K shares 884K $12.99 323.84K
Q4 2017 share Decrease -16.97% -73.83K shares -183K $9.2 361.16K
Q3 2017 share Increase +2181.43% 415.93K shares 3.39M $8.06 435K
Q2 2017 share Decrease -78.35% -69K shares -269K $5.76 19.06K
Q1 2017 share Increase 0.00% 88.06K shares 379K $4.3 88.06K